Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma

PURPOSE: High-dose methotrexate based chemotherapy is the standard treatment for patients with newly diagnosed primary central nervous system lymphoma (PCNSL). The role of rituximab is controversial because of its large size, which limits its penetration of the blood-brain barrier. In this study, we...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Sun, Xuefei, Liu, Jing, Wang, Yaming, Bai, Xueyan, Chen, Yuedan, Qian, Jun, Zhu, Hong, Liu, Fusheng, Qiu, Xiaoguang, Sun, Shengjun, Ji, Nan, Liu, Yuanbo
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564757/
https://ncbi.nlm.nih.gov/pubmed/28467782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17101
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы